Notably, mutations in RUNX2 are linked to cleidocranial dysplasia, a skeletal disorder frequently accompanied by cognitive deficits, suggesting that RUNX2 and its downstream target OCN may have broader roles beyond bone development (Takenouchi et al., 2014). This evidence concerns the gene BGLAP and Cognitive impairment.